Structural Heart Market Report 2026

Structural Heart Market Overview

• Structural Heart market size has reached to $15.89 billion in 2025 • Expected to grow to $24.6 billion in 2030 at a compound annual growth rate (CAGR) of 9.2% • Growth Driver: Surging Prevalence Of Cardiovascular Disorders Driving Growth In The Structural Heart Market • Market Trend: Innovative Product Developments In The Structural Heart Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Structural Heart Market?

Structural heart refers to a subspecialty within cardiology that focuses on the diagnosis and treatment of structural abnormalities or diseases of the heart, particularly those affecting the valves, chambers, and surrounding structures. It typically involves minimally invasive procedures performed in a catheterization laboratory rather than open-heart surgery. The main types of structural heart products are occluders, annuloplasty rings, heart valve balloons, and others. Occluder systems are designed to offer a conduit for devices to be injected into the heart's chambers and coronary arteries, as well as the peripheral vasculature, and these devices are used in patients with certain types of atrial septal defects with right atrial or ventricle enlargement to prevent paradoxical embolism. The various procedures that use structural heart products are heart valve stenosis, heart valve regurgitation, and left atrial appendage closure which are used by different end-users such as hospitals, ambulatory surgical centers, and cardiac centers.

What Is The Structural Heart Market Growth Forecast?

The structural heart market size is expected to see strong growth in the next few years. It will grow to $24.6 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to growing demand for transcatheter therapies, increasing investments in structural heart programs, expansion of cardiac centers of excellence, advancements in device miniaturization, rising focus on reducing open-heart surgery rates. Major trends in the forecast period include increasing adoption of transcatheter valve procedures, rising use of minimally invasive structural heart interventions, growing integration of advanced cardiac imaging, expansion of catheter-based repair technologies, enhanced focus on patient-specific treatment planning.

Global Structural Heart Market Segmentation

1) By Product: Occluders, Annuloplasty Rings, Heart Valve Balloons, Other Products 2) By Procedure: Heart Valve Stenosis, Heart Valve Regurgitation, Left Atrial Appendage Closure 3) By End Users: Hospitals, Cardiac Centers Subsegments: 1) By Occluders: Atrial Septal Defect (ASD) Occluders, Patent Foramen Ovale (PFO) Occluders, Ventricular Septal Defect (VSD) Occluders 2) By Annuloplasty Rings: Rigid Annuloplasty Rings, Flexible Annuloplasty Rings, Adjustable Annuloplasty Rings 3) By Heart Valve Balloons: Balloon Expandable Heart Valve Systems, Valvuloplasty Balloons 4) By Other Products: Transcatheter Heart Valves, Structural Heart Imaging Devices, Delivery Systems For Structural Heart Procedures

What Is The Driver Of The Structural Heart Market?

The rising prevalence of cardiovascular disorders is expected to propel the growth of the structural heart market going forward. Cardiovascular disorders are diseases that affect the heart and blood vessels and include conditions such as coronary artery disease, heart failure, and stroke. The rising prevalence of cardiovascular disorders is mostly driven by the aging population, changes in lifestyle and diet, and increasing rates of obesity and diabetes. Structural heart devices and services offer diagnosis and treatment of structural heart anomalies or disorders that affect the valves, chambers, and surrounding tissues using minimally invasive procedures performed rather than open-heart surgery for efficient treatment with lower-risk complications. For instance, in September 2025, according to the British Heart Foundation, a UK-based charity, across the UK, more than 7.6 million people—over 4 million men and more than 3.6 million women—are living with cardiovascular disease, and projections indicate that, driven by an aging population and improved survival rates, the number of affected individuals may rise by around 1 million by 2030 and by approximately 2 million by 2040. Therefore, the rising prevalence of cardiovascular disorders is driving the growth of the structural heart industry.

Key Players In The Global Structural Heart Market

Major companies operating in the structural heart market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Lepu Medical Technology Co. Ltd., LivaNova PLC, Venus Medtech (Hangzhou) Inc., CryoLife Inc., Endologix Inc., Braile Biomédica, JenaValve Technology Inc., Corvia Medical Inc., On-X Life Technologies Inc., Symetis SA, Micro Interventional Devices Inc., CardioKinetix Inc., Tendyne Holdings Inc., Neovasc Inc., NVT AG, Biomerics LLC, Shockwave Medical Inc., HLT Medical, Q'Apel Medical Inc., Z-Medical GmbH + Co. KG

Global Structural Heart Market Trends and Insights

Major companies operating in the structural heart market are developing advanced products, such as transcatheter edge-to-edge repair (TEER) systems, to enhance minimally invasive treatment options for heart valve diseases. Transcatheter edge-to-edge repair (TEER) systems are minimally invasive medical devices used to treat heart valve diseases, particularly mitral valve regurgitation. For instance, in April 2024, Abbott Laboratories, a US-based medical device company, received approval from the Food and Drug Administration (FDA), a US-based federal agency for protecting public health. TriClip. TriClip is an innovative transcatheter edge-to-edge repair (TEER) system. This minimally invasive device is delivered through a vein in the leg, enabling valve repair without the need for open-heart surgery, making it suitable for patients who may be at higher risk due to age or existing health issues. The device works by using clips to grasp and bring together the leaflets of the tricuspid valve, thereby reducing regurgitation and improving blood flow.

What Are Latest Mergers And Acquisitions In The Structural Heart Market?

In July 2024, Edwards Lifesciences, a US-based provider of structural heart disease therapies and critical care monitoring technologies, acquired JenaValve Technology and Endotronix for approximately $1.2 billion. With this acquisition, Edwards aims to expand its structural heart portfolio by entering new therapeutic areas, strengthening its innovation pipeline, and addressing substantial unmet needs in aortic regurgitation and heart failure care. JenaValve Technology is a Germany-based developer of transcatheter aortic valve replacement solutions for aortic regurgitation, while Endotronix is a US-based provider of implantable hemodynamic monitoring systems and digital heart failure management platforms.

Regional Outlook

North America was the largest region in the structural heart market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Structural Heart Market?

The structural heart market consists of revenues earned by entities by providing services such as patient evaluation, diagnosis, treatment planning, surgical or interventional procedures, and follow-up care. The market value includes the value of related goods sold by the service provider or included within the service offering. The structural heart market also includes sales of transcatheter heart valves, closure devices, and implantable devices that are used during procedures. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.